Less than whole uterus irradiation for patients with locally advanced cervical cancer
Despite the preventability of cervical cancer with the introduction of the human papilloma virus (HPV) vaccine, cervical cancer remains the second leading cause of cancer death in women under the age of 40 [1]. Although the outcomes of cervical cancer are excellent for patients with early-stage disease, the 5-year disease free survival for locally advanced disease drops to around 70 %, highlighting the importance of further optimizing treatment of cervical cancer [2–8].
Source: Radiotherapy and Oncology - Category: Radiology Authors: Caressa Hui, Agnes Ewongwo, Maria G. Mendoza, Margaret M. Kozak, Scott Jackson, Jie Fu, Elizabeth Kidd Tags: Original Article Source Type: research
More News: Cancer | Cancer & Oncology | Cancer of the Uterus | Cancer Vaccines | Cervical Cancer | Cervical Cancer Vaccine | Human Papillomavirus (HPV) | Men | Radiology | Vaccines | Women